![Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial - The Lancet Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/0af83eda-db0a-4a26-8f88-e4384c0333f6/gr1.jpg)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial - The Lancet
![PDF) Muscarinic Receptor Activation Induces Differential Effects on Schwann and Oligodendrocyte Cells | Antonietta Bernardo, Ada M Tata, Valerio Magnaghi, and Federica Angelis - Academia.edu PDF) Muscarinic Receptor Activation Induces Differential Effects on Schwann and Oligodendrocyte Cells | Antonietta Bernardo, Ada M Tata, Valerio Magnaghi, and Federica Angelis - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46089566/mini_magick20180819-15765-y1qtfb.png?1534714224)
PDF) Muscarinic Receptor Activation Induces Differential Effects on Schwann and Oligodendrocyte Cells | Antonietta Bernardo, Ada M Tata, Valerio Magnaghi, and Federica Angelis - Academia.edu
![Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study - eBioMedicine Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study - eBioMedicine](https://www.thelancet.com/cms/attachment/c897b9ad-5f82-410e-98b0-0f1282871b8b/gr2_lrg.jpg)
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study - eBioMedicine
![Pharmaceutics | Free Full-Text | Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications Pharmaceutics | Free Full-Text | Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-02463/article_deploy/html/images/pharmaceutics-14-02463-g001.png)
Pharmaceutics | Free Full-Text | Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications
![The overlapping burden of the three leading causes of disability and death in sub-Saharan African children | Nature Communications The overlapping burden of the three leading causes of disability and death in sub-Saharan African children | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34240-6/MediaObjects/41467_2022_34240_Fig1_HTML.png)
The overlapping burden of the three leading causes of disability and death in sub-Saharan African children | Nature Communications
![Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 | Nature Medicine Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-0807-6/MediaObjects/41591_2020_807_Fig1_HTML.png)
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 | Nature Medicine
![Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://www.thelancet.com/cms/attachment/736a79af-cfc6-4ee1-8fc8-655362a05949/gr1_lrg.jpg)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case‐Control and Case‐Crossover Settings: A Systematic Review and Meta‐Analysis - Frederiksen - 2020 - Headache: The Journal Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case‐Control and Case‐Crossover Settings: A Systematic Review and Meta‐Analysis - Frederiksen - 2020 - Headache: The Journal](https://headachejournal.onlinelibrary.wiley.com/cms/asset/ec85fef2-e687-42c5-9f7d-f7024fa3b77c/head.v60.6.cover.jpg?trick=1673878295767)